Senegalese delegation with Dr. Yot Teerawattananon, Dr. Wanrudee Isaranuwatchai and Aparna Ananthakrishnan from HITAP We are very honored to have participated in the Health Technology Assessment (HTA) training and symposium.We have seen interestin

The Prince Mahidol Award Conference (PMAC) 2020 took place in Bangkok between January 28th and February 2nd. This year PMAC was combined with the Universal Health Coverage (UHC) Forum, and the theme for the conference was Accelerating Progress towards UHC. Every year the conference attracts an array

As economic evaluation methods are constantly changing and developing, it is important to stay abreast of the latest developments so that any beneficial new techniques are utilised, where possible, to maximise the public health impact of health economics and health technology assessment (HT

On 21st September 2020, HITAP joined representatives of the Ministry of Public Health (MOPH) Thailand and the National Health Security Office (NHSO) at the Kenyan Universal Health Coverage (UHC) Fund Taskforce meeting chaired by Mr. Geoffrey Malombe from National Treasury and Dr. Mercy Mwangangi, Ch

As we approach the end of an unprecedented year, the approval of select COVID-19 vaccines by stringent regulatory authorities and programmatic roll-out has been cause for optimism. However, it is imperative to assure equitable access to those in need in all regions of the world as a core component o

To support government decision-making to address the COVID-19 outbreak, the National Data Management Center (NDMC) of the Ethiopia Public Health Institute (EPHI) conducted a systematic review of the economic evaluations of public health measures for the prevention and control of pandemics. The study

Vaccines have been a game-changer in the fight against COVID-19. Yet, vaccine hesitancy has impeded its uptake, impacting public health efforts. At the outset of the pandemic, people had doubts about this unfamiliar virus and subsequently, the vaccine: misinformation, rumours, and doubts about COVID

The decision-making challenge for reimbursing costly innovative drugs Health technology assessment (HTA) is a multi-disciplinary approach crucial to the decision-making framework for drug reimbursements. It gives evidence of the drug’s cost-effectiveness and affordability to help policymakers decide

Beyond expectations – More than 100 abstracts and almost 20 pre-conference session proposals are submitted and will be carefully reviewed by the Scientific Committee. Thank you for your interest and contribution to our network!Results of the review will be sent to the author/s by 30 September 2022 v

Since its inception, health technology assessment (HTA) has assisted governments across the world through evidence-informed health resources allocation and it all begins at the Office of Technology Assessment (OTA), United States Congress led by Dr. David Banta.This video is a tribute to Dr. David B